Bazedoxifene - CAS# 198481-32-2 t A Inhibition is also seen at

Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs)

126(1):136-47

5-3(6)1-2-4(7)8/h3-9

a member of the hematopoietin receptor superfamily

and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2

Bazedoxifene - CAS# 198481-32-2 t A Inhibition is also seen atBazedoxifene, also known as WAY 140424, is a third generation selective estrogen receptor modulator (SERM), developed by Pfizer following the completion of their takeover of Wyeth Pharmaceuticals. In late 2013, Pfizer received approval for bazedoxifene as part of the combination drug DUAVEE in the prevention (not treatment) of postmenopausal osteoporosis. Bazedoxifene is an indole based ER ligand that binds to both ER (IC50 = 26 nM) and ER (IC50 = 99